Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://covid19.nih.gov/

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Name Principal Investigator Institution Study Date Approved Project ID
Examining Questionnaire-Based Risk Factors for Recurrent Colorectal Adenoma in the PLCO Cancer Screening Trial: Tea, Coffee, and Caffeine intake Jiyoung Ahn NCI, DCEG, NEB PLCO Nov 10, 2008 2008-0055
Examining Questionnaire-Based Risk Factors for Recurrent Colorectal Adenoma in the PLCO Cancer Screening Trial: Smoking behavior Linda Laio NCI, DCEG, OEEB PLCO Nov 10, 2008 2008-0051
Examining Questionnaire-Based Risk Factors for Recurrent Colorectal Adenoma in the PLCO Cancer Screening Trial: Energy balance (body mass index, physical activity, and energy intake) Cari Kitahara NCI, DCEG, NEB PLCO Nov 10, 2008 2008-0052
Examining Questionnaire-Based Risk Factors for Recurrent Colorectal Adenoma in the PLCO Cancer Screening Trial: Fatty Acid and Fish Consumption Jiyoung Ahn NCI, DCEG, NEB PLCO Nov 10, 2008 2008-0056
Examining Questionnaire-Based Risk Factors for Recurrent Colorectal Adenoma in the PLCO Cancer Screening Trial: Calcium and Dairy Products Linda Laio NCI, DCEG, OEEB PLCO Nov 10, 2008 2008-0050
Genome-wide Association Study of Adenoma Risk in the PLCO Trial Sonja Berndt NCI, DCEG, OEEB PLCO Nov 10, 2008 2008-0035
Examining Questionnaire-Based Risk Factors for Recurrent Colorectal Adenoma in the PLCO Cancer Screening Trial: Fruits and Vegetables, Fiber, and Family History Sonja Berndt NCI, DCEG, OEEB PLCO Nov 10, 2008 2008-0054
Effect of circulating androgens and sex hormones on serum PSA levels in the PLCO study Robert Grubb Washington University School of Medicine in St. Louis PLCO Oct 22, 2008 2008-0044
Effect of circulating factors on serum PSA levels in the PLCO study Robert Grubb Washington University School of Medicine in St. Louis PLCO Oct 22, 2008 2008-0045
DNA Extraction Method, Biological Specimen, and DNA Yield for Genetic Studies in PLCO Leah Mechanic Westat PLCO Oct 9, 2008 2008-0042
Meat, meat cooking methods and meat mutagens, and lung cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Natasa Tasevska NCI, DCEG, NEB PLCO Sep 26, 2008 2008-0023
Value of a confirmatory PSA test in men undergoing screening for prostate cancer Amanda Black NCI, DCEG, EBP PLCO Sep 26, 2008 2008-0033
Lung Cancer Risk Prediction – A Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Study Martin Tammemagi Brock University / Henry Ford Health System PLCO Sep 26, 2008 2008-0031
Flavonoid intake and the risk of pancreatic cancer in the PLCO Cancer Screening Trial Gerd Bobe NCI-F, CCR, LCP PLCO Sep 12, 2008 2008-0041
Baseline PSA and 7 Year Risk of Prostate Cancer Diagnosis Amanda Black NCI, DCEG, EBP PLCO Sep 11, 2008 2008-0036
Flavonoid intake and the risk of colorectal carcinogenesis in the PLCO Cancer Screening Trial Gerd Bobe NCI-F, CCR, LCP PLCO Sep 11, 2008 2008-0037
Estrogens and Estrogen Metabolites (EMs) and the Risk of Endometrial Cancer in a Nested Case-Control Study in the Prostate, Lung, Ovarian, and Colorectal Cancer Screening Trial (PLCO) Regina Ziegler - PLCO Aug 29, 2008 2007-0257
Smoking Cessation and Relapse in the National Lung Screening Trial Martin Tammemagi Henry Ford Health System NLST Aug 22, 2008 2007-00042
Establishment of Screening Center Satellites Bonita Wohlers University of Utah/Boise NLST Jul 23, 2008 2008-00042
Predictors of Vitamin D status (as measured by 25(OH)D in serum) : in particular BMI, Exercise and Dietary intake and Season Barry Graubard NCI, DCEG, BB PLCO Jun 20, 2008 2008-0018